Cargando…

miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma

To identify ‘melanoma-specific’ microRNAs (miRNAs) we used an unbiased microRNA profiling approach to comprehensively study cutaneous melanoma in relation to other solid malignancies, which revealed 233 differentially expressed (≥2 fold, p < 0.05) miRNAs. Among the top 20 most significantly diffe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stark, Mitchell S., Bonazzi, Vanessa F., Boyle, Glen M., Palmer, Jane M., Symmons, Judith, Lanagan, Catherine M., Schmidt, Christopher W., Herington, Adrian C., Ballotti, Robert, Pollock, Pamela M., Hayward, Nicholas K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627343/ https://www.ncbi.nlm.nih.gov/pubmed/25980496

Ejemplares similares

The ‘melanoma-enriched’ microRNA miR-4731-5p acts as a tumour suppressor
por: Stark, Mitchell S., et al.
Publicado: (2016)

Melanoma: BRAFi Rechallenge
por: Kosmidis, Christoforos S., et al.
Publicado: (2023)

Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?
por: Prasad, Chandra Prakash, et al.
Publicado: (2015)

Changes in the Transcriptome and Chromatin Landscape in BRAFi-Resistant Melanoma Cells
por: Reddi, Kiran Kumar, et al.
Publicado: (2022)

The AhR‐SRC axis as a therapeutic vulnerability in BRAFi‐resistant melanoma
por: Paris, Anaïs, et al.
Publicado: (2022)

Proteomics and Phosphoproteomics Profiling of Drug-Addicted BRAFi-Resistant Melanoma Cells
por: Li, Bohui, et al.
Publicado: (2021)

Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma
por: Krayem, Mohammad, et al.
Publicado: (2018)

Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells
por: Fratangelo, Federica, et al.
Publicado: (2018)

The Role of Senescent Cells in Acquired Drug Resistance and Secondary Cancer in BRAFi-Treated Melanoma
por: Thompson, Elizabeth L., et al.
Publicado: (2021)

Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype
por: Ohanna, Mickaël, et al.
Publicado: (2013)

Harnessing host innate immunity may combat acquired resistance to BRAFi
por: Tan, Thomas, et al.
Publicado: (2014)

Cross-Platform Array Screening Identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as Genes Frequently Silenced by Methylation in Melanoma
por: Bonazzi, Vanessa F., et al.
Publicado: (2011)

Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients
por: Rogala, Paweł, et al.
Publicado: (2022)

BRAF/EZH2 Signaling Represses miR-129-5p Inhibition of SOX4 Thereby Modulating BRAFi Resistance in Melanoma
por: Gebhardt, Kathleen, et al.
Publicado: (2021)

5.14 The Biophysics of Membrane Fusion
por: Collins, R.N., et al.
Publicado: (2012)

514. The Effect of Probiotics on the Incidence of Clostridium difficile
por: Saltzman, Temima, et al.
Publicado: (2018)

514 The Outcomes of Tracheostomy on Burn Inhalation injuries
por: Ruiz, Samuel G, et al.
Publicado: (2022)

miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways
por: Sun, Xiaoyan, et al.
Publicado: (2016)

The Rb1 tumour suppressor gene modifies telomeric chromatin architecture by regulating TERRA expression
por: Gonzalez-Vasconcellos, I., et al.
Publicado: (2017)

The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis()
por: Stark, Mitchell S., et al.
Publicado: (2015)

2-Methoxyestradiol-3,17-O,O-bis-sulfamate (STX140) Inhibits Proliferation and Invasion via Senescence Pathway Induction in Human BRAFi-Resistant Melanoma Cells
por: Franco, Ylana Adami, et al.
Publicado: (2023)

The distinct role of strand-specific miR-514b-3p and miR-514b-5p in colorectal cancer metastasis
por: Ren, Lin-Lin, et al.
Publicado: (2018)

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
por: Yokoyama, Satoru, et al.
Publicado: (2011)

Characterization of the Melanoma miRNAome by Deep Sequencing
por: Stark, Mitchell S., et al.
Publicado: (2010)

Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers
por: Pritchard, Antonia L., et al.
Publicado: (2018)

The −514C/T Polymorphism of Hepatic Lipase Gene among Iranian Patients with Coronary Heart Disease
por: Ghatreh Samani, K, et al.
Publicado: (2012)

Geographic and Socioeconomic Disparity in Child Undernutrition across 514 Districts in Indonesia
por: Ayuningtyas, Dumilah, et al.
Publicado: (2022)

Disparities in Obesity Rates among Adults: Analysis of 514 Districts in Indonesia
por: Ayuningtyas, Dumilah, et al.
Publicado: (2022)

Heterogeneity in Melanoma
por: Ng, Mei Fong, et al.
Publicado: (2022)

An intermittent extreme BL Lac: MWL study of 1ES 2344+514 in an enhanced state
por: Ansoldi, S., et al.
Publicado: (2020)

Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine
por: Oo, Zay Yar, et al.
Publicado: (2019)

Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation
por: Greco, Sonia A, et al.
Publicado: (2010)

CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma
por: Alon, Michal, et al.
Publicado: (2018)

Frequent somatic MAP3K5 and MAP3K9 mutations in metastatic melanoma identified by exome sequencing
por: Stark, Mitchell S, et al.
Publicado: (2011)

Tumour Suppressor Neuron Navigator 3 and Matrix Metalloproteinase 14 are Co-expressed in Most Melanomas but Downregulated in Thick Tumours
por: BUGAEVA, Olga, et al.
Publicado: (2023)

Response of Photofrin-sensitised mesothelioma xenografts to photodynamic therapy with 514 nm light.
por: Foster, T. H., et al.
Publicado: (1996)

MON-514 Bone Density Yo-yo In A Patient With Severe Hypercalciuria
por: Thakkar, Aditi, et al.
Publicado: (2019)

SUN-514 Severe Hypophosphatemia and Worsening Secondary Hyperparathyroidism Following Treatment with Denosumab
por: Adepoju, Yewande, et al.
Publicado: (2019)

SAT-514 Nivolumab Related Primary Hypothyroidism: 3 Years of Follow-Up
por: Baby, Ann Pia, et al.
Publicado: (2020)

Growing Up Unequal: Disparities of Childhood Overweight and Obesity in Indonesia’s 514 Districts
por: Sulistiadi, Wahyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8u2se4t7a1d37mniabehch93oq